0001420506-20-001346.txt : 20201123
0001420506-20-001346.hdr.sgml : 20201123
20201120194237
ACCESSION NUMBER: 0001420506-20-001346
CONFORMED SUBMISSION TYPE: 13F-HR
PUBLIC DOCUMENT COUNT: 2
CONFORMED PERIOD OF REPORT: 20200930
FILED AS OF DATE: 20201123
DATE AS OF CHANGE: 20201120
EFFECTIVENESS DATE: 20201123
FILER:
COMPANY DATA:
COMPANY CONFORMED NAME: RHO CAPITAL PARTNERS INC
CENTRAL INDEX KEY: 0001020455
IRS NUMBER: 133087622
STATE OF INCORPORATION: NY
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 13F-HR
SEC ACT: 1934 Act
SEC FILE NUMBER: 028-05883
FILM NUMBER: 201333949
BUSINESS ADDRESS:
STREET 1: 152 WEST 57TH STREET
STREET 2: 23RD FLOOR
CITY: NEW YORK
STATE: NY
ZIP: 10019
BUSINESS PHONE: 2127516677
MAIL ADDRESS:
STREET 1: 152 WEST 57TH STREET
STREET 2: 23RD FLOOR
CITY: NEW YORK
STATE: NY
ZIP: 10019
FORMER COMPANY:
FORMER CONFORMED NAME: RHO MANAGEMENT CO INC
DATE OF NAME CHANGE: 19960806
13F-HR
1
primary_doc.xml
13F-HR
LIVE
false
true
false
0001020455
XXXXXXXX
09-30-2020
09-30-2020
false
RHO CAPITAL PARTNERS INC
152 WEST 57TH STREET
23RD FLOOR
NEW YORK
NY
10019
13F HOLDINGS REPORT
028-05883
N
Peter E. Kalkanis
Chief Financial Officer
2127516677
Peter E. Kalkanis, Chief Financial Officer
NEW YORK
NY
11-20-2020
0
5
120102
false
INFORMATION TABLE
2
Form13F_InfoTable.xml
INFORMATION TABLE FOR RHO CAPITAL PARTNERS INC
CARA THERAPEUTICS INC
COM
140755109
35618
2799058
SH
SOLE
2799058
0
0
LIVEXLIVE MEDIA INC
COM NEW
53839L208
9664
3724138
SH
SOLE
3724138
0
0
MERSANA THERAPEUTICS INC
COM
59045L106
14830
796458
SH
SOLE
796458
0
0
NGM BIOPHARMACEUTICALS INC
COM
62921N105
59928
3766666
SH
SOLE
3766666
0
0
SENSEONICS HLDGS INC
COM
81727U105
62
159601
SH
SOLE
159601
0
0